A Simplified Diagnostic and Therapeutic Approach to Pulmonary Hypertension

被引：2
作者：
Gupta, Tripti [1 ,2 ]
Shariati, Farnoosh [3 ]
Krim, Selim R. [1 ,2 ,4 ]
机构：
[1] Ochsner Med Ctr, John Ochsner Heart & Vasc Inst, New Orleans, LA 70121 USA
[2] Univ Queensland, Sch Med, Ochsner Clin Sch, New Orleans, LA 70121 USA
[3] Ochsner Med Ctr, Div Internal Med, New Orleans, LA USA
[4] Ochsner Clin Fdn, John Ochsner Heart & Vasc Inst, Sect Cardiomyopathy & Heart Transplantat, New Orleans, LA USA
来源：
CURRENT PROBLEMS IN CARDIOLOGY | 2022年 / 47卷 / 04期
关键词：
ARTERIAL-HYPERTENSION; PERICARDIAL-EFFUSION; MANAGEMENT; OUTCOMES; REGISTRY;
D O I：
10.1016/j.cpcardiol.2021.100857
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pulmonary hypertension remains a common but complex disorder that physicians face in their daily practice. Pulmonary hypertension has been classified by the World Health Organization into five major categories according to etiology, pathophysiology, and hemodynamic properties. The clinical course and overall prognosis varies by etiology, therefore making the correct diagnosis is paramount to avoid delay in treatment and improve outcomes. This review aims to provide clinicians with a simplified diagnostic approach to pulmonary hypertension. We also provide a guide to risk stratification and when to refer patient to a pulmonary hypertension expert center.
引用
收藏
页数：14
相关论文
共 24 条
  • [1] Pulmonary Arterial Hypertension Baseline Characteristics From the REVEAL Registry
    Badesch, David B.
    Raskob, Gary E.
    Elliott, C. Greg
    Krichman, Abby M.
    Farber, Harrison W.
    Frost, Adaani E.
    Barst, Robyn. J.
    Benza, Raymond L.
    Liou, Theodore G.
    Turner, Michelle
    Giles, Scott
    Feldkircher, Kathy
    Miller, Dave P.
    McGoon, Michael D.
    [J]. CHEST, 2010, 137 (02) : 376 - 387
  • [2] Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis
    Benza, Raymond L.
    Miller, Dave P.
    Foreman, Aimee J.
    Frost, Adaani E.
    Badesch, David B.
    Benton, Wade W.
    McGoon, Michael D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (03) : 356 - 361
  • [3] The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
    Benza, Raymond L.
    Gomberg-Maitland, Mardi
    Miller, Dave P.
    Frost, Adaani
    Frantz, Robert P.
    Foreman, Aimee J.
    Badesch, David B.
    McGoon, Michael D.
    [J]. CHEST, 2012, 141 (02) : 354 - 362
  • [4] Evaluating suspected pulmonary hypertension: A structured approach
    Bhatnagar, Akshay
    Wiesen, Jonathan
    Dweik, Raed
    Chaisson, Neal F.
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2018, 85 (06) : 468 - 480
  • [5] A noninvasive algorithm to exclude pre-capillary pulmonary hypertension
    Bonderman, D.
    Wexberg, P.
    Martischnig, A. M.
    Heinzl, H.
    Lang, M-B
    Sadushi, R.
    Skoro-Sajer, N.
    Lang, I. M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (05) : 1096 - 1103
  • [6] Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    Boucly, Athenais
    Weatherald, Jason
    Savale, Laurent
    Jais, Xavier
    Cottin, Vincent
    Prevot, Gregoire
    Picard, Francois
    de Groote, Pascal
    Jevnikar, Mitja
    Bergot, Emmanuel
    Chaouat, Ari
    Chabanne, Celine
    Bourdin, Arnaud
    Parent, Florence
    Montani, David
    Simonneau, Gerald
    Humbert, Marc
    Sitbon, Olivier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [7] Fan R, 2015, INT J RESPIR PULM ME, V2, P031
  • [8] Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
    Farber, Harrison W.
    Miller, Dave P.
    Poms, Abby D.
    Badesch, David B.
    Frost, Adaani E.
    Muros-Le Rouzic, Erwan
    Romero, Alain J.
    Benton, Wade W.
    Elliott, C. Gregory
    McGoon, Michael D.
    Benza, Raymond L.
    [J]. CHEST, 2015, 148 (04) : 1043 - 1054
  • [9] Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
    Galie, N.
    Barbera, J. A.
    Frost, A. E.
    Ghofrani, H-A.
    Hoeper, M. M.
    McLaughlin, V. V.
    Peacock, A. J.
    Simonneau, G.
    Vachiery, J-L.
    Gruenig, E.
    Oudiz, R. J.
    Vonk-Noordegraaf, A.
    White, R. J.
    Blair, C.
    Gillies, H.
    Miller, K. L.
    Harris, J. H. N.
    Langley, J.
    Rubin, L. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (09) : 834 - 844
  • [10] Risk stratification and medical therapy of pulmonary arterial hypertension
    Galie, Nazzareno
    Channick, Richard N.
    Frantz, Robert P.
    Gruenig, Ekkehard
    Jing, Zhi Cheng
    Moiseeva, Olga
    Preston, Ioana R.
    Pulido, Tomas
    Safdar, Zeenat
    Tamura, Yuichi
    McLaughlin, Vallerie V.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
123